-
22
JunAvesthagen Wipro have launched genetic tests for cancer, neurological disorders, and rare diseases
Wipro's expertise in genomics and biomarker discovery will assist Avesthagen in developing well-regulated workflows during the development of CALiBRx® gene panels. The tests would primarily…
admin no responses -
21
JunWipro surges on entering into four-year strategic alliance with Avesthagen
Together, Avesthagen and Wipro will execute the project titled, ‘Cancer Risk Assessed by NGS profiling of Circulating free DNA and RNA for Lung Cancer Project…
admin no responses -
20
JunAvesthagen launches breakthrough genetic testing portfolio for cancer and other diseases; Enters strategic alliance with Wipro
Meanwhile, the India launch will be followed by expansion in South Asia, Southeast Asia and the MENA region in Q4 2022. Over the next decade,…
admin no responses -
20
JunAvesthagen Limited enters into strategic alliance with Wipro; launches breakthrough Genetic Testing Portfolio for Cancers, Neurological and Rare Diseases
Avesthagen Limited, a biotechnology major that specializes in predictive, preventive and personalized healthcare through the convergence of food, pharma and population genetics, has entered into…
admin no responses
UK OFFICE
CORPORATE HEADQUARTERS